tirzepatide compound ending Compounded – BloomMD 1 and GIP therapy Compounded Tirzepatide | $360/mo, No

SURMOUNT-1 results (72 weeks, adults with obesity): 5 mg dose: approximately 15% body weight loss 10 mg dose: 19.5% body weight loss 15 mg dose: 22.5% body weight loss Placebo: 3.1% body weight loss At the 15 mg maximum dose, the average participant lost about 52 pounds over 72 weeks

Its approximately six-day half-life maintains stable plasma concentrations throughout the week, so consistent adherence to a chosen day matters far more than the specific hour

The biggest mistake I see is waiting too long to pivot

Although no head to head trials comparing tirzepatide to semaglutide 2mg exists, an adjusted indirect treatment comparison study aimed to compare these two agents based on the results from SURPASS 2 and SUSTAIN FORTE

Dai Z-h, Xu X-t, Ran Z-h

Patients often begin to experience reduced appetite and initial weight loss during this phase